1              The proximal half received only lipofectin.

2  into S.pombe protoplasts in the presence of lipofectin.

3 ts in the presence of serum when compared to Lipofectin.

4 teries was treated with Rz or MRz mixed with lipofectin.

5 on of expression exceeded that observed with Lipofectin.

6 SP CTL and Th epitopes in Montanide's ISA51, Lipofectin, and Lipofectamine.

7 ncies greater than or comparable to DMRIE-C, Lipofectin, and Lipofectamine.

8 a lysine-glycine core [MAP4(PyCSP57-70)] and Lipofectin as the adjuvant induced both T-cell prolifera

9 the compounds were several times better than Lipofectin at promoting DNA uptake.

10                               Similarly, ODN:Lipofectin complexes moderately increased cell associati

11 derivatized siRNA could be delivered without lipofectin complexing and in the presence of serum.

12                                  Exposure of Lipofectin-DNA complexes to the partially purified G gly

13 cient gene transfer than cationic liposomes (lipofectin, lipofectamine, and DOTAP).

14 nt as compared to the commercially available Lipofectin liposome, and (iii) is > or = 20-fold more ef

15 es at 3-wk intervals of MAP(280-299)p2p30 in Lipofectin or Lipofectamine.

16 the promoter-reporter constructs by means of Lipofectin reagent.

17 vities lasted 48 and 72 h following a single Lipofectin treatment with antisense JNK1 and JNK2, respe

18                          ODN associated with Lipofectin was also studied.

19 he mice immunized with MAP(280-299)p2p30 and Lipofectin were protected against sporozoite challenge.